Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy: Two-Year Results of the Aflibercept in Polypoidal Choroidal Vasculopathy Study-Reference-Cited by-同舟云学术

Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy: Two-Year Results of the Aflibercept in Polypoidal Choroidal Vasculopathy Study

Published:2019-08 Issue: Volume:204 Page:80-89
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Wong Tien Yin,Ogura Yuichiro,Lee Won Ki,Iida Tomohiro,Chen Shih-Jen,Mitchell Paul,Gemmy Cheung Chui Ming,Zhang Zhongqi,Leal Sérgio,Ishibashi Tatsuro

Funder

Novartis

Bayer

Abbott

Allergan

Genentech

Roche

Pfizer

Santen

Alcon

Topcon Medical Systems Inc

Bayer AG

Publisher

Elsevier BV

Subject

Ophthalmology

Reference39 articles.

1. Idiopathic polypoidal choroidal vasculopathy (IPCV);Yannuzzi;Retina,1990

2. Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment;Koh;Retina,2013

3. Polypoidal choroidal vasculopathy in Chinese patients;Kwok;Br J Ophthalmol,2002

4. Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients;Byeon;Jpn J Ophthalmol,2008

5. Polypoidal choroidal vasculopathy and treatments;Gomi;Curr Opin Ophthalmol,2008

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pachychoroid disease: review and update;Eye;2024-08-03

2. Macular neovascularization;Survey of Ophthalmology;2024-08

3. Verteporfin Photodynamic Therapy for the Treatment of Chorioretinal Conditions: A Narrative Review;Clinical Ophthalmology;2024-06

4. Evaluating photodynamic therapy versus brolucizumab as a second-line treatment for polypoidal choroidal vasculopathy;International Journal of Retina and Vitreous;2024-04-08

5. AI-based support for optical coherence tomography in age-related macular degeneration;International Journal of Retina and Vitreous;2024-04-08